Does GUSELKUMAB Cause Device deployment issue? 778 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 778 reports of Device deployment issue have been filed in association with GUSELKUMAB (TREMFYA). This represents 2.8% of all adverse event reports for GUSELKUMAB.
778
Reports of Device deployment issue with GUSELKUMAB
2.8%
of all GUSELKUMAB reports
0
Deaths
4
Hospitalizations
How Dangerous Is Device deployment issue From GUSELKUMAB?
Of the 778 reports, 4 (0.5%) required hospitalization.
Is Device deployment issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for GUSELKUMAB. However, 778 reports have been filed with the FAERS database.
What Other Side Effects Does GUSELKUMAB Cause?
Product dose omission issue (9,267)
Accidental exposure to product (2,941)
Drug ineffective (1,971)
Needle issue (1,933)
Psoriasis (1,817)
Device issue (1,613)
Device malfunction (1,410)
Off label use (1,186)
Product storage error (1,017)
Inappropriate schedule of product administration (830)
What Other Drugs Cause Device deployment issue?
ETONOGESTREL (3,621)
GOLIMUMAB (1,265)
COPPER (768)
LEVONORGESTREL (718)
USTEKINUMAB (639)
SUMATRIPTAN (292)
PEGFILGRASTIM (163)
ABATACEPT (131)
SOMATROPIN (130)
CARBIDOPA\LEVODOPA (88)
Which GUSELKUMAB Alternatives Have Lower Device deployment issue Risk?
GUSELKUMAB vs HAIR KERATIN AMINO ACIDS GOLD COMPLEX
GUSELKUMAB vs HALDOL
GUSELKUMAB vs HALOBETASOL
GUSELKUMAB vs HALOPERIDOL
GUSELKUMAB vs HALOPERIDOL DECANOATE